These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28654953)

  • 1. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
    Kwa M; Welty LJ; Xu S
    JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Personal Care Products Safety Act.
    Feinstein D; Collins S
    JAMA Intern Med; 2018 May; 178(5):601-602. PubMed ID: 29404567
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 4. Mirror, mirror on the wall, what's in my personal care products: a short article about 300 million "guinea pigs".
    Sattler B; Archer L; Houlihan J
    Oreg Nurse; 2006 Sep; 71(3):10. PubMed ID: 16989178
    [No Abstract]   [Full Text] [Related]  

  • 5. Recalls of foods and cosmetics due to microbial contamination reported to the U.S. Food and Drug Administration.
    Wong S; Street D; Delgado SI; Klontz KC
    J Food Prot; 2000 Aug; 63(8):1113-6. PubMed ID: 10945589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants.
    Cornell E; Kwa M; Paller AS; Xu S
    Pediatr Dermatol; 2018 Mar; 35(2):225-229. PubMed ID: 29575075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modernizing regulation of cosmetic products: Reintroduction of the Personal Care Products Safety Act.
    Nguyen HP; Bergfeld WF; Forman HP; Belsito DV; Bolognia JL
    J Am Acad Dermatol; 2018 Aug; 79(2):403-405. PubMed ID: 29625132
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of the standards of proof (of safety) for FDA regulated consumer products and how the generally recognized as safe criteria could be applied to cosmetics.
    Burdock GA
    Regul Toxicol Pharmacol; 2024 May; 149():105603. PubMed ID: 38494042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time for a makeover-cosmetics regulation in the United States.
    Cornell EM; Janetos TM; Xu S
    J Cosmet Dermatol; 2019 Dec; 18(6):2041-2047. PubMed ID: 30950176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB; Tressler L
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dermatologically tested, can it be done in a better fashion?].
    Bruynzeel DP; Coenraads PJ; Meinardi MM; van Joost T
    Ned Tijdschr Geneeskd; 1993 Sep; 137(38):1908-10. PubMed ID: 8413690
    [No Abstract]   [Full Text] [Related]  

  • 13. Cosmetic safety: is there any?
    Simmons S
    Nursing; 2012 May; 42(5):54-5. PubMed ID: 22531078
    [No Abstract]   [Full Text] [Related]  

  • 14. Governance, stewardship and cosmetics.
    Contact Dermatitis; 2014 May; 70(5):261. PubMed ID: 24731082
    [No Abstract]   [Full Text] [Related]  

  • 15. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007.
    Kornfeld-Lecanu S; Zajaczkowski F; Dubourg S; Martin L; Lefort S; Siest S
    Clin Exp Dermatol; 2010 Dec; 35(8):874-80. PubMed ID: 20718782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety assessment of cosmetic ingredients present in technical information files of finished products.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():94-114. PubMed ID: 18806455
    [No Abstract]   [Full Text] [Related]  

  • 17. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 18. Not in my makeup: the need for enhanced premarket regulatory authority over cosmetics in light of increased usage of engineered nanoparticles.
    Johnson DR
    J Contemp Health Law Policy; 2009; 26(1):82-124. PubMed ID: 20112620
    [No Abstract]   [Full Text] [Related]  

  • 19. Tattoo ink-related infections--awareness, diagnosis, reporting, and prevention.
    LeBlanc PM; Hollinger KA; Klontz KC
    N Engl J Med; 2012 Sep; 367(11):985-7. PubMed ID: 22913662
    [No Abstract]   [Full Text] [Related]  

  • 20. Health effects of personal care products: a review of the evidence.
    Russ K
    Nurs Womens Health; 2009 Oct; 13(5):392-401. PubMed ID: 19821915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.